Income Statement
VOYAGER THERAPEUTICS, INC.
VYGR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
40.37 | 80.00 | 250.01 | 40.91 | 37.42 | 171.13 | 104.39 | 11.10 | 10.14 | 14.22 | 17.33 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
40.37 | 80.00 | 250.01 | 40.91 | 37.42 | 171.13 | 104.39 | 11.10 | 10.14 | 14.22 | 17.33 |
|
Operating Expenses
|
172.22 | 163.29 | 127.99 | 91.74 | 111.03 | 143.74 | 156.07 | 98.71 | 82.00 | 55.52 | 37.59 |
|
Research & Development
|
134.67 | 127.37 | 92.17 | 60.76 | 73.79 | 108.75 | 119.74 | 64.91 | 62.26 | 42.25 | 27.68 |
|
Selling, General & Administrative
|
37.54 | 35.92 | 35.82 | 30.98 | 37.25 | 34.99 | 36.34 | 33.81 | 19.74 | 13.27 | 9.91 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-131.84 | -83.29 | 122.01 | -50.84 | -73.62 | 27.38 | -51.68 | -87.62 | -71.86 | -41.30 | -20.25 |
|
Non-Operating Income
|
12.27 | 18.95 | 11.72 | 4.45 | 2.42 | 9.36 | 8.08 | 2.63 | 1.17 | 1.16 | - |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
1.65 | 0.62 | 0.00 | 2.65 | 2.81 | 7.70 | 1.63 | -0.68 | -0.06 | 0.18 | - |
|
Income Before Tax
|
-119.58 | -64.34 | 133.74 | -46.39 | - | 36.74 | -43.60 | -3.48 | -70.70 | -40.14 | - |
|
Income Tax Expense
|
0.14 | 0.67 | 1.41 | 0.02 | - | 0.00 | 0.00 | -0.18 | 0.00 | 0.05 | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-119.72 | -65.00 | 132.33 | -46.41 | -71.20 | 36.74 | -43.60 | -88.29 | -70.70 | -40.19 | -29.67 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-131.84 | -83.29 | 122.01 | -50.84 | -73.62 | 27.38 | -51.68 | -87.62 | -71.86 | -41.30 | -20.25 |
|
Earnings Per Share (Basic)
|
-2.04 | -1.13 | 3.08 | -1.21 | -1.89 | 0.99 | - | - | - | - | - |
|
Diluted EPS
|
-2.04 | -1.13 | 2.97 | -1.21 | -1.89 | 0.98 | - | - | - | - | - |
|
Weighted Average Shares
|
58.69 | 57.67 | 43.02 | 38.36 | 37.67 | 37.13 | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
58.69 | 57.67 | 44.57 | 38.36 | 37.67 | 37.35 | - | - | - | - | - |
|
Comprehensive Income
|
-119.28 | -65.36 | 132.50 | -46.49 | -71.20 | 36.71 | -43.57 | -88.25 | -70.93 | -39.99 | -29.92 |